Girolami Antonio, Minoldo Salvador, Ferrari Silvia, Colussi Diego, Lombardi Anna Maria, Guglielmone Hugo
Department of Medicine, University of Padua Medical School, Padua, Italy.
Universidad Nacional de Cordoba y Sanatorio Allende, Cordoba, Argentina.
Cardiovasc Hematol Disord Drug Targets. 2017;17(2):136-141. doi: 10.2174/1871529X17666170908105839.
The aim was to report a new family with congenital FX deficiency.
The proposita is a 41 year old female with a moderate bleeding tendency (easy bruising, menorrhagia). Parents were not consanguineous. Family history was positive for a mild bleeding tendency.
Coagulation and genetics studies revealed that the proposita and two of her siblings were heterozygotes for a new mutation Cys241Gly in exon 6 but had different FX level (2-3% of normal in the proposita and about 50% in the two siblings. The same was true for one of her three children. The mother and the other two children of the proposita had also slightly decreased FX levels but no mutation. On the suspicion that the proposita was carrying another defect which had escaped the Sanger method, we carried out a whole exome analysis and discovered that the proposita and one of her siblings were also homozygous for a mutation of a known polymorphism (c.503-57C>T). The daughter of the proposita was instead, besides being a carrier of the missense new mutation Cys241Gly, heterozygous for the same polymorphism. The mother and two other daughters were also heterozygous for the polymorphism. There were no deletions or duplications.
The polymorphism present in the family seems to be capable of potentiating the defect induced by the new mutation. This, safe for epigenetics phenomena, is the only possible explanation for the discrepancy found in the FX level between mother and daughter despite the fact that both carried the same new mutation.
